TAMMY PARRETT: Open Payments
NPI 1699706028 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,233 in 131 payments from 22 companies in 2025. Trend: 2023 $2,574 · 2024 $3,030 · 2025 $3,233
Food & beverage: $3,233
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 21 | $531 |
| GlaxoSmithKline, LLC. | 23 | $408 |
| Viatris Specialty LLC | 17 | $385 |
| Vifor Pharma, Inc. | 4 | $346 |
| United Therapeutics Corporation | 13 | $327 |
| AstraZeneca Pharmaceuticals LP | 12 | $302 |
| Insmed, Inc. | 9 | $260 |
| Merck Sharp & Dohme LLC | 7 | $119 |
| GENZYME CORPORATION | 3 | $101 |
| Amgen Inc. | 4 | $72 |
Products named: Ohtuvayre, YUPELRI, NUCALA, Zemaira, Tyvaso, Arikayce, DUPIXENT, BREZTRI.
Industry payments across NC — which companies pay providers there.
